Related references
Note: Only part of the references are listed.Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients
Jan-Hendrik Naendrup et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2022)
COVID-19 associated EBV reactivation and effects of ganciclovir treatment
Mei Meng et al.
IMMUNITY INFLAMMATION AND DISEASE (2022)
Baricitinib for the Management of SARS-CoV-2-Infected Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Sivananthan Manoharan et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2022)
Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis
Sivananthan Manoharan et al.
RESPIRATORY MEDICINE (2022)
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
Jose Luis Rodriguez-Garcia et al.
RHEUMATOLOGY (2021)
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
Stefania Paolucci et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation
Yun Xie et al.
BMC INFECTIOUS DISEASES (2021)
Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence
Timothy Hugh Barker et al.
BMC MEDICAL RESEARCH METHODOLOGY (2021)
Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients
Ting Chen et al.
SCIENTIFIC REPORTS (2021)
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Jeffrey E. Gold et al.
PATHOGENS (2021)
Herpesvirus reactivation during severe COVID-19 and high rate of immune defect
A. Saade et al.
INFECTIOUS DISEASES NOW (2021)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression
Eric V. Yang et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)